|
1 Bacigalupo A, Hows J, Gordon–Smith EC, et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: A report of the BMT Working Party. Bone Marrow Transplant，1988，3(6)：531–535.
|
|
2 Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: A prospective study of the effect of early marrow transplantion on acute mortality.Blood，1976，48(1)：63–70.
|
|
3 Chen C, Fang JP, Huang SL，et al.The clinical analysis of the efficacy of immunosuppressive therapy in 54 children patients with severe aplastic anemia. Chin J Pediatr.2006，44(11)：841–844.
|
|
4 Stary J，Locatelli F，Niemeyer CM，et al.Stem cell transplantation for aplastic anemia and myelodysplastic syndrome.Bone Marrow Transplant, 2005，35(suppl 1)：S13–S16.
|
|
5 Further M，Rampf U，Baumann I，et al.Immunosuppressive therapy for aplasic anemia in children：A more severe disease predicts better survival.Blood，2005，106(6)：2102–2104.
|
|
6 Jeng MR，Naidu PE，Rieman MD，et al.Granulocyte–macrophage colony stimulating factor and immunosuppression in the treatment of pediatric aquired severe aplastic anemia. Pediatr Blood Cancer, 2005, 45(2): 170–175.
|
|
7 Killick SB，Marsh JC，Gordon–Smith EC，et al.Long–term outcome of aquired aplastic anemia in children：Comparison between immunosuppressive therapy and bone marrow transplantation.Br J Haematol, 2000, 111: 321–328.
|
|
8 Goldenberg NA，Graham DK，Liang X，et al.Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A．Pediatr Blood Cancer, 2004，43(7)：718–722.
|
|
9 Kojima S，Hibi S，Kosaka Y，et al.Immunosuppressive therapy using antithymocyte globulin，cyclosporine, and danazol with or without human granulocyte colony–stimulating factor in children with acquired apastic anemia.Blood，2000，96(6)：2049–2054.
|
|
10 Scheinberg P, Wu CO, Nunez O, et al.Long–term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.J Pediatr，2008，153(6)：814–819.
|
|
11 Lu J，Chai YH, Cao YF，et al. The clinical prophase observation of the therapeutic effect of antilymphocyte globulin combining cyclosporin A in treatment of pediatric severe aplastic anemia.China Pediatr Blood，2005, 10(3)：103–105.
|
|
12 Futher M，Burdach S，Ebell W，et al.Relapse and clonal disease in chidren with aplastic anemia after immunosuppressive therapy(IST)：The SAA 94 experience.German/Austrian Pediatric Aplastic Anemia Working Group. Klin Pediatr，1998，210(4)：173–179.
|
|
13 De–Medeiros CR，Ribeiro RC，Bittencourt MA.Long–term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin.Braz J Med Biol Res，2000，33(5)：553–558.
|
|
14 Socie G, Mary JY, Schrezenmeier H, et al. Granulocyte–stimulating factor and severe aplastic anemia: A survey by the European Group for Blood and Marrow Transplantation (EBMT)．Blood，2007 109(7): 2794–2796.
|
|
15 Shichino H，Mugishima H，Takamura M，et al.Treatment of aplastic anemia with antithymocyte globulin，cyclosporin A，methylprednisolone, danazol and recombinant human grannlocyte–colony stimulating factor. Acta Paediatr Jpn，1996，38(6)：644–647.
|
|
16 Huang YL, Huang SL.Progress of immune–mediated pathogenesis and treatment in children patients with aplastic anemia. Chin J Pediatr，2006，44(2)：153–155.
|
|
17 Yong NS, Maciejewski JP. Aplastic anemia. In: Ronald H. Hematology–basic principles and practice.3rd ed.Beijing ：Harcourt Asia Churchill Livingstone，2001，297–331.
|
|
18 Mourad G, Garrigue V, Squifflet JP, et al. Induction versus moninduction in renal transplant recipients with tacrolimus–based immunosuppression. Transplantation，2001，72(6)：1050–1055.
|